Investors are poised to add Medtronic Plc (MDT) Stock to their long term portfolios

Ulysses Smith

At the time of writing, Medtronic Plc [MDT] stock is trading at $100.29, up 1.71%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MDT shares have gain 4.01% over the last week, with a monthly amount glided 1.84%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on January 06, 2026, when William Blair upgraded its rating to a Outperform. Previously, Goldman upgraded its rating to Neutral on November 19, 2025, and kept the price target unchanged to $111. On June 30, 2025, upgrade upgraded it’s rating to Peer Perform. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $110 on June 16, 2025. Citigroup upgraded its rating to a Buy and raised its price target to $107 on March 04, 2025. RBC Capital Mkts upgraded its rating to Outperform for this stock on October 10, 2024, and upped its price target to $105. In a note dated August 21, 2024, Oppenheimer reiterated an Perform rating on this stock and boosted its target price from $92 to $94.

For the past year, the stock price of Medtronic Plc fluctuated between $79.55 and $106.33. Currently, Wall Street analysts expect the stock to reach $111.67 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $100.29 at the most recent close of the market. An investor can expect a potential return of 11.35% based on the average MDT price forecast.

Analyzing the MDT fundamentals

According to Medtronic Plc [NYSE:MDT], the company’s sales were 34.76B for trailing twelve months, which represents an 6.64% jump. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.1 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It is important to note that Medtronic Plc [NYSE:MDT] has a current ratio of 2.42. In addition, the Quick Ratio stands at 1.80 and the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 3.70, the price to book ratio is 2.64 and price to earnings (TTM) ratio is 27.09.

Transactions by insiders

Recent insider trading involved Smith Gregory L, EVP Global Ops & Supply Chain, that happened on Nov 19 ’25 when 30000.0 shares were sold. Officer, Smith Gregory L completed a deal on Nov 19 ’25 to buy 30000.0 shares. Meanwhile, EVP & President Cardiovascular KIIL HARRY SKIP sold 8605.0 shares on Sep 03 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.